Biotechnology in China
Published: August 2013 · Publisher: MarketLine
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Chinese biotechnology market had total revenues of $13.3bn in 2012, representing a compound annual growth rate (CAGR) of 16.2% between 2008 and 2012.
*Chinese state council decided to focus on the domestic biotech industry to tackle problems such as food safety and energy conservation, as well as environment protection.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 15.7% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $27.5bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the China economy
Key Questions Answered
What was the size of the China biotechnology market by value in 2012?
What will be the size of the China biotechnology market in 2017?
What factors are affecting the strength of competition in the China biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up China's biotechnology market?
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Chinese biotechnology market had total revenues of $13.3bn in 2012, representing a compound annual growth rate (CAGR) of 16.2% between 2008 and 2012.
*Chinese state council decided to focus on the domestic biotech industry to tackle problems such as food safety and energy conservation, as well as environment protection.
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 15.7% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $27.5bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the China economy
Key Questions Answered
What was the size of the China biotechnology market by value in 2012?
What will be the size of the China biotechnology market in 2017?
What factors are affecting the strength of competition in the China biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up China's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
#N/A
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Novo Nordisk A/S 19
Shanghai Kehua Bio-engineering Co., Ltd 22
Sinovac Biotech Ltd. 26
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related research 32
LIST OF TABLES
Table 1: China biotechnology market value: $ billion, 2008–12 8
Table 2: China biotechnology market category segmentation: $ billion, 2012 9
Table 3: China biotechnology market geography segmentation: $ billion, 2012 10
Table 4: China biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Novo Nordisk A/S: key facts 19
Table 6: Novo Nordisk A/S: key financials ($) 20
Table 7: Novo Nordisk A/S: key financials (DKK) 20
Table 8: Novo Nordisk A/S: key financial ratios 20
Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts 22
Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($) 23
Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY) 23
Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios 24
Table 13: Sinovac Biotech Ltd.: key facts 26
Table 14: Sinovac Biotech Ltd.: key financials ($) 26
Table 15: Sinovac Biotech Ltd.: key financial ratios 27
Table 16: China size of population (million), 2008–12 29
Table 17: China gdp (constant 2000 prices, $ billion), 2008–12 29
Table 18: China gdp (current prices, $ billion), 2008–12 29
Table 19: China inflation, 2008–12 30
Table 20: China consumer price index (absolute), 2008–12 30
Table 21: China exchange rate, 2008–12 30
LIST OF FIGURES
Figure 1: China biotechnology market value: $ billion, 2008–12 8
Figure 2: China biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: China biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: China biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in China, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in China, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in China, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in China, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in China, 2012 18
Figure 11: Novo Nordisk A/S: revenues & profitability 21
Figure 12: Shanghai Kehua Bio-engineering Co., Ltd: revenues & profitability 24
Figure 13: Shanghai Kehua Bio-engineering Co., Ltd: assets & liabilities 25
Figure 14: Sinovac Biotech Ltd.: revenues & profitability 27
Figure 15: Sinovac Biotech Ltd.: assets & liabilities 28
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Novo Nordisk A/S 19
Shanghai Kehua Bio-engineering Co., Ltd 22
Sinovac Biotech Ltd. 26
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related research 32
LIST OF TABLES
Table 1: China biotechnology market value: $ billion, 2008–12 8
Table 2: China biotechnology market category segmentation: $ billion, 2012 9
Table 3: China biotechnology market geography segmentation: $ billion, 2012 10
Table 4: China biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Novo Nordisk A/S: key facts 19
Table 6: Novo Nordisk A/S: key financials ($) 20
Table 7: Novo Nordisk A/S: key financials (DKK) 20
Table 8: Novo Nordisk A/S: key financial ratios 20
Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts 22
Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($) 23
Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY) 23
Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios 24
Table 13: Sinovac Biotech Ltd.: key facts 26
Table 14: Sinovac Biotech Ltd.: key financials ($) 26
Table 15: Sinovac Biotech Ltd.: key financial ratios 27
Table 16: China size of population (million), 2008–12 29
Table 17: China gdp (constant 2000 prices, $ billion), 2008–12 29
Table 18: China gdp (current prices, $ billion), 2008–12 29
Table 19: China inflation, 2008–12 30
Table 20: China consumer price index (absolute), 2008–12 30
Table 21: China exchange rate, 2008–12 30
LIST OF FIGURES
Figure 1: China biotechnology market value: $ billion, 2008–12 8
Figure 2: China biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: China biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: China biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in China, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in China, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in China, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in China, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in China, 2012 18
Figure 11: Novo Nordisk A/S: revenues & profitability 21
Figure 12: Shanghai Kehua Bio-engineering Co., Ltd: revenues & profitability 24
Figure 13: Shanghai Kehua Bio-engineering Co., Ltd: assets & liabilities 25
Figure 14: Sinovac Biotech Ltd.: revenues & profitability 27
Figure 15: Sinovac Biotech Ltd.: assets & liabilities 28
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.